A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery.

A pH-sensitive prodrug, TPGS-CHN-DOX, was introduced by conjugating anticancer drug, doxorubicin (DOX), onto d-α-tocopherol polyethylene glycol 1000 succinate (TPGS) via a cleavable Schiff base linkage. The prodrug was mixed with a PEGylated lipid to form a simple but multifunctional hybrid micelle system, which can realize high drug loading capability and biocompatibility, extended blood circulation time, inhibited drug resistance in cancer cells, improved therapeutic response, reduced side effects, and easy functionalities for targeting delivery. The hybrid micelles exhibited in vitro pH-sensitive drug release, enhanced cellular uptake and strengthened cytotoxicity on both drug-sensitive human breast cancer MCF-7 and resistant MCF-7/ADR cells. P-glycoprotein functional inhibition and mitochondria-associated cell apoptosis induced by TPGS were thought to play an important role in overcoming the multidrug resistance. As a result, the hybrid micelles demonstrated good anticancer efficacy in MCF-7/ADR xenograft model. Additionally, after modifying with a tumor-specific targeting peptic ligand, cRGD, the tumor growth/metastasis inhibition was further evidenced in integrin receptor overexpressed melanoma cancer B16F10 and even murine hepatocarcinoma H22 models. This TPGS-based pH-sensitive prodrug provides a safe and "Molecular economical" way in the rational design of prodrugs for overcoming multidrug resistance and targeting delivery, which can improve the potency for clinical use.

[1]  Y. Bae,et al.  Doxorubicin loaded pH-sensitive micelle targeting acidic extracellular pH of human ovarian A2780 tumor in mice , 2005, Journal of drug targeting.

[2]  Ruth Duncan,et al.  Polymer conjugates as anticancer nanomedicines , 2006, Nature Reviews Cancer.

[3]  Eun-Kyung Lim,et al.  pH‐Triggered Drug‐Releasing Magnetic Nanoparticles for Cancer Therapy Guided by Molecular Imaging by MRI , 2011, Advanced materials.

[4]  M. Vicent,et al.  Polymer therapeutics-prospects for 21st century: the end of the beginning. , 2013, Advanced drug delivery reviews.

[5]  Zhiping Zhang,et al.  D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells. , 2014, Molecular pharmaceutics.

[6]  W. Mark Saltzman,et al.  Drug Delivery: Engineering Principles for Drug Therapy , 2001 .

[7]  Jun Wang,et al.  Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells. , 2011, ACS nano.

[8]  X. Qi,et al.  Roles of ligand and TPGS of micelles in regulating internalization, penetration and accumulation against sensitive or resistant tumor and therapy for multidrug resistant tumors. , 2015, Biomaterials.

[9]  Emanuel Fleige,et al.  Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications. , 2012, Advanced drug delivery reviews.

[10]  Mauro Ferrari,et al.  Principles of nanoparticle design for overcoming biological barriers to drug delivery , 2015, Nature Biotechnology.

[11]  H. Cui,et al.  Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles. , 2015, Acta biomaterialia.

[12]  S. Feng,et al.  Doxorubicin conjugated to D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS): conjugation chemistry, characterization, in vitro and in vivo evaluation. , 2008, Biomaterials.

[13]  X. Qi,et al.  Enhance Cancer Cell Recognition and Overcome Drug Resistance Using Hyaluronic Acid and α-Tocopheryl Succinate Based Multifunctional Nanoparticles. , 2015, Molecular pharmaceutics.

[14]  P. Couvreur,et al.  A unique squalenoylated and nonpegylated doxorubicin nanomedicine with systemic long-circulating properties and anticancer activity , 2014, Proceedings of the National Academy of Sciences.

[15]  Yaping Li,et al.  Synergistic inhibition of breast cancer metastasis by silibinin-loaded lipid nanoparticles containing TPGS. , 2013, International journal of pharmaceutics.

[16]  V. Torchilin,et al.  Enhanced anticancer activity of nanopreparation containing an MMP2-sensitive PEG-drug conjugate and cell-penetrating moiety , 2013, Proceedings of the National Academy of Sciences.

[17]  R. Kumar,et al.  Self‐Assembly of PEG and Diester Copolymers: Effect of PEG Length, Linker, Concentration and Temperature , 2005 .

[18]  L. Murray,et al.  Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  Zhiping Zhang,et al.  Cell or Cell Membrane-Based Drug Delivery Systems , 2015, Theranostics.

[20]  E Crivellato,et al.  Handling of doxorubicin by the LLC-PK1 kidney epithelial cell line. , 1998, The Journal of pharmacology and experimental therapeutics.

[21]  G. P. Agrawal,et al.  Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[22]  Hao Liu,et al.  An improved D-α-tocopherol-based nanocarrier for targeted delivery of doxorubicin with reversal of multidrug resistance. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[23]  V. Mohanraj,et al.  Nanoparticles - A Review , 2007 .

[24]  R K Jain,et al.  Noninvasive measurement of interstitial pH profiles in normal and neoplastic tissue using fluorescence ratio imaging microscopy. , 1994, Cancer research.

[25]  Yaping Li,et al.  A TPGS-incorporating nanoemulsion of paclitaxel circumvents drug resistance in breast cancer. , 2014, International journal of pharmaceutics.

[26]  H. Schiff.  Mittheilungen aus dem Universitätslaboratorium in Pisa: Eine neue Reihe organischer Basen , 1864 .

[27]  Xing-jie Liang,et al.  Functionalized nanoscale micelles improve drug delivery for cancer therapy in vitro and in vivo. , 2013, Nano letters.

[28]  Maurizio Fermeglia,et al.  Anticancer drug nanomicelles formed by self-assembling amphiphilic dendrimer to combat cancer drug resistance , 2015, Proceedings of the National Academy of Sciences.

[29]  Atul Kolate,et al.  PEG - a versatile conjugating ligand for drugs and drug delivery systems. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[30]  R. Schiffelers,et al.  RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature. , 2005, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[31]  Xiaoyan Liu,et al.  A novel nanoassembled doxorubicin prodrug with a high drug loading for anticancer drug delivery. , 2014, Journal of materials chemistry. B.

[32]  K. Ulbrich,et al.  Biodegradable star HPMA polymer-drug conjugates: Biodegradability, distribution and anti-tumor efficacy. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[33]  Mengyun Peng,et al.  Self-delivery of a peptide-based prodrug for tumor-targeting therapy , 2016, Nano Research.

[34]  David A. Cheresh,et al.  Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging , 1998, Nature Medicine.

[35]  Synthesis of aromatic Schiff base oligomers at the air/water interface , 1985 .

[36]  Jianbin Tang,et al.  The Role of Micelle Size in Tumor Accumulation, Penetration, and Treatment. , 2015, ACS nano.

[37]  Xiangliang Yang,et al.  Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance. , 2014, Molecular pharmaceutics.

[38]  Xing Guo,et al.  pH-triggered intracellular release from actively targeting polymer micelles. , 2013, Biomaterials.

[39]  K. Otake,et al.  Development of a New Preparation Method of Liposomes Using Supercritical Carbon Dioxide , 2001 .

[40]  P. Carmeliet,et al.  Molecular mechanisms of blood vessel growth. , 2001, Cardiovascular research.

[41]  D. Arosio,et al.  Advancement in integrin facilitated drug delivery. , 2016, Advanced drug delivery reviews.

[42]  Zhiping Zhang,et al.  pH-sensitive docetaxel-loaded D-α-tocopheryl polyethylene glycol succinate-poly(β-amino ester) copolymer nanoparticles for overcoming multidrug resistance. , 2013, Biomacromolecules.

[43]  Y. Barenholz,et al.  Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. , 1994, Cancer research.

[44]  A. Ohtsu,et al.  Phase I Study of NK012, a Novel SN-38–Incorporating Micellar Nanoparticle, in Adult Patients with Solid Tumors , 2010, Clinical Cancer Research.

[45]  Zhiping Zhang,et al.  The applications of Vitamin E TPGS in drug delivery. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[46]  Jeffrey A. Hubbell,et al.  Enhancing Drug Function , 2003, Science.

[47]  Weihong Tan,et al.  Nanotechnology in therapeutics : a focus on nanoparticles as a drug delivery system Review , 2008 .

[48]  S K Carter,et al.  Adriamycin. A new anticancer drug with significant clinical activity. , 1974, Annals of internal medicine.

[49]  Anil K Patri,et al.  Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex. , 2005, Advanced drug delivery reviews.

[50]  David John Adams,et al.  Cyclic-RGDfK peptide conjugated succinoyl-TPGS nanomicelles for targeted delivery of docetaxel to integrin receptor over-expressing angiogenic tumours. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[51]  Xiu-fang Wang,et al.  Vitamin E analogues as a novel group of mitocans: anti-cancer agents that act by targeting mitochondria. , 2007, Molecular aspects of medicine.

[52]  K. Ghoshal,et al.  MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. , 2007, Gastroenterology.

[53]  John Calvin Reed.  Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities , 2006, Cell Death and Differentiation.